Benzoylecgonine 0.36 µg/mL in Autopsy: Interpretation Guide

Benzoylecgonine (BE) is the major stable metabolite of cocaine. A postmortem blood concentration of 0.36 µg/mL (360 ng/mL) indicates recent cocaine exposure. Interpretation requires context.

What This Level Suggests

• Recent Use: Cocaine used within ~12–48 hours of death (BE half-life ~6–12 hrs in life; postmortem redistribution complicates).
• Not Directly Lethal: Fatal cocaine toxicity typically shows BE >1–2 µg/mL (often 5–20+ µg/mL). 0.36 µg/mL is moderate.
• Possible Contribution: Cocaine's acute effects (vasoconstriction, arrhythmia, hyperthermia, seizure) may have precipitated death even at moderate levels, especially with comorbidities (heart disease, polydrug use).

Critical Interpretive Factors

Factor	Impact on Interpretation
Postmortem Redistribution (PMR)	BE redistributes from liver/GI → central blood. Central (heart) levels 2–5× peripheral. Site matters.
Sample Type	Blood (heart, femoral, iliac), urine, vitreous, bile, hair. Urine: high conc = exposure window days-weeks.
Co-administration	Other stimulants, opioids, alcohol → synergistic toxicity.
Chronic Use	Tolerance shifts lethal threshold higher.
Age/PMI/Temp	Degradation, bacterial production (minor for BE).

Standard Forensic Workup

1. Quantitative BE + parent cocaine (if detectable) in femoral blood (less PMR) and urine.
2. Comprehensive toxicology panel (LC-MS/MS).
3. Scene investigation: paraphernalia, witness accounts.
4. Histology: myocardial contraction bands, cerebral edema.
5. Correlation with cause/manner of death opinion.

Reporting

State: "Benzoylecgonine 0.36 µg/mL in femoral blood. Consistent with recent cocaine use. Contribution to death cannot be excluded; correlated with clinical circumstances."

Reference: Baselt, Disposition of Toxic Drugs and Chemicals in Man; SOFT/AAFS guidelines.